• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>KongZhong Corporation ADR

KongZhong Corporation ADR

Genting Hong Kong Ltd GTHKF

Last Price$0.26Day Change (%)0.00%
Open Price$0.27Day Change ($)0.00
Day Range0.26–0.2752-Week Range0.25–0.32

As of Fri 9/8/2017 10:56:00 AM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. UPDATE: This city has the best quality of life in the world (hint: it's not in the U.S.)

    UPDATE: This city has the best quality of life in the world (hint: it's not in the U.S.)

  2. ASIA MARKETS: Nikkei Gains Steam, Outpacing Other Asian Markets

    ASIA MARKETS: Nikkei Gains Steam, Outpacing Other Asian Markets

  3. Google Jumps Back Into Hardware With $1.1 Billion HTC Deal -- 2nd Update

    Google Jumps Back Into Hardware With $1.1 Billion HTC Deal -- 2nd Update

  4. UPDATE: Nikkei gains steam, outpacing other Asian markets

    UPDATE: Nikkei gains steam, outpacing other Asian markets

  5. ASIA MARKETS: Nikkei Gains Steam, Outpacing Other Asian Markets

    ASIA MARKETS: Nikkei Gains Steam, Outpacing Other Asian Markets

  6. Nikkei gains steam, outpacing other Asian markets

    Nikkei gains steam, outpacing other Asian markets

  7. Jack Ma-Linked Online Insurer Readies IPO -- WSJ

    Jack Ma-Linked Online Insurer Readies IPO -- WSJ

  8. Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from New Zealand’s Medicines and Medical Devices Safety Authority

    Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from New Zealand’s Medicines and Medical Devices Safety Authority

  9. Innovus Pharma Announces the Launch of Zestra® in France, Belgium and Monaco by Its Partner, Densmore

    Innovus Pharma Announces the Launch of Zestra® in France, Belgium and Monaco by Its Partner, Densmore

  10. Eze Software Grows Platform, Adds Clients In APAC

    Eze Software Grows Platform, Adds Clients In APAC

12345

©2017 Morningstar Advisor. All right reserved.